摘要
本文对88例急性心肌梗塞患者中溶栓治疗组30例与其他综合治疗的对照组58例作了疗效比较,结果显示两组血管再通率分别为66.7%和38.8%(P<0.DI);4周病死率分别为10.0%和18.9%(P<0.05),病人所患休克、心力衰竭、严重心律失常、梗塞延展和梗塞后。心绞痛所占比率分别为3.3%、16.6%、23.3%、6.6%、13.3%、10.3%、37.9%、34.4%、12.1%、27.5%。提示溶栓治疗的疗效明显优于对照组,而且其严重并发症、梗塞延展和梗塞后心绞痛的发生明显减少。
In this article, 88 cases of patients with acute myocardiac infarction were diveded into therapeutic group of 30 cases and control group of 58 cases, and the thrombolytic effect of acute myocardiac infarction in the former group was studied compared with the control group. The results showed that the blood vessel redeoppolation rates were respectively 66. 7% and 38. 8% (P<0. 01). Death rate in four weeks were 10. 0% and 18. 9%. The rates of patients with shock, cardiac asthenia, postinfarctional duration and postinfarctional angina pectoris were respectively 3.3%, 16. 6%, 23. 3%, 6. 6%, 13. 3 and 10.3%. 37. 9%, 34. 4%, 12,l%, 27. 5%. As aresult, the curative effect of therapeutic group was better than that of control group.And the occurance of severe complications,postinfarctional duration and postinfarctional angina pectoris reduced.
出处
《中国冶金工业医学杂志》
1996年第2期67-68,共2页
Chinese Medical Journal of Metallurgical industry
关键词
心肌梗塞
溶栓治疗
尿激酶
Myocardiac infarction
Thrombolytic treatment
Urokinase